Kymera Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 6.87 M | $276.40 M | 3.38% | 9.03% |
| BAKER BROS. ADVISORS LP | 02/14/2025 | 6.00 M | $241.22 M | 0.00% | 7.88% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 5.31 M | $213.51 M | 14.92% | 6.97% |
| BVF INC/IL | 02/14/2025 | 5.16 M | $207.66 M | 0.00% | 6.78% |
| AVORO CAPITAL ADVISORS LLC | 02/14/2025 | 5.15 M | $207.18 M | 14.44% | 6.77% |
| ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | 02/06/2025 | 4.90 M | $196.98 M | 0.00% | 6.43% |
| VANGUARD GROUP INC | 02/11/2025 | 4.89 M | $196.62 M | 2.81% | 6.42% |
| FMR LLC | 02/13/2025 | 4.83 M | $194.33 M | -5.46% | 6.35% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 4.36 M | $175.25 M | 3.43% | 5.72% |
| SIREN, L.L.C. | 02/14/2025 | 2.97 M | $119.47 M | 0.00% | 3.90% |
| STATE STREET CORP | 02/14/2025 | 1.69 M | $67.94 M | -2.28% | 2.22% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/14/2025 | 1.39 M | $55.93 M | 4.64% | 1.83% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.11 M | $44.48 M | 4.96% | 1.45% |
| REDMILE GROUP, LLC | 02/14/2025 | 1.10 M | $44.27 M | -21.02% | 1.45% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 1.03 M | $41.60 M | -1.45% | 1.36% |
| MERCK & CO., INC. | 02/14/2025 | 772,165 | $31.06 M | 100.00% | 1.01% |
| JENNISON ASSOCIATES LLC | 01/24/2025 | 716,933 | $28.84 M | -10.12% | 0.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/14/2025 | 593,000 | $23.86 M | 100.00% | 0.78% |
| WOODLINE PARTNERS LP | 02/14/2025 | 537,428 | $21.62 M | 2.35% | 0.71% |
| AVIDITY PARTNERS MANAGEMENT LP | 02/14/2025 | 500,000 | $20.12 M | 0.00% | 0.66% |
| UBS GROUP AG | 02/14/2025 | 469,842 | $18.90 M | 115.90% | 0.62% |
| EVENTIDE ASSET MANAGEMENT, LLC | 02/14/2025 | 455,728 | $18.33 M | -10.27% | 0.60% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 433,944 | $17.46 M | 93.01% | 0.57% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 433,755 | $17.45 M | -8.22% | 0.57% |
| 02/14/2025 | 425,000 | $17.10 M | 100.00% | 0.56% | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 02/12/2025 | 419,490 | $16.88 M | -7.47% | 0.55% |
| DEER MANAGEMENT CO. LLC | 02/14/2025 | 415,895 | $16.73 M | 0.00% | 0.55% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 404,667 | $16.28 M | -5.57% | 0.53% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 387,187 | $15.58 M | 5.55% | 0.51% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 02/14/2025 | 383,310 | $15.42 M | -5.67% | 0.50% |
| JANUS HENDERSON GROUP PLC | 02/14/2025 | 377,384 | $15.20 M | 2,397.91% | 0.50% |
| ECOR1 CAPITAL, LLC | 02/14/2025 | 350,000 | $14.08 M | 100.00% | 0.46% |
| GILDER GAGNON HOWE & CO LLC | 02/14/2025 | 326,349 | $13.13 M | 12.02% | 0.43% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 260,300 | $10.47 M | -22.60% | 0.34% |
| TD ASSET MANAGEMENT INC | 02/11/2025 | 228,560 | $9.19 M | 10.47% | 0.30% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2025 | 215,480 | $8.67 M | 20.25% | 0.28% |
| AQUILO CAPITAL MANAGEMENT, LLC | 02/14/2025 | 183,521 | $7.38 M | -12.08% | 0.24% |
| FIRST TRUST ADVISORS LP | 02/13/2025 | 176,220 | $7.09 M | 43.22% | 0.23% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 173,753 | $6.99 M | -35.66% | 0.23% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 02/12/2025 | 163,896 | $6.44 M | 14.06% | 0.22% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 02/14/2025 | 150,172 | $6.04 M | -61.72% | 0.20% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/14/2025 | 147,296 | $5.93 M | 14.84% | 0.19% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 02/14/2025 | 147,238 | $5.92 M | -37.28% | 0.19% |
| FORESITE CAPITAL MANAGEMENT VI LLC | 02/14/2025 | 146,332 | $5.89 M | 100.00% | 0.19% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 143,225 | $5.76 M | 2.17% | 0.19% |
| ATIKA CAPITAL MANAGEMENT LLC | 02/13/2025 | 136,500 | $5.49 M | 40.72% | 0.18% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 127,093 | $5.11 M | 4.48% | 0.17% |
| SOROS FUND MANAGEMENT LLC | 02/14/2025 | 120,373 | $4.84 M | 100.00% | 0.16% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 115,918 | $4.66 M | 205.00% | 0.15% |
| 02/28/2025 | 114,587 | $4.61 M | 100.00% | 0.15% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Kymera Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 207 institutional investors and hedge funds held shares of Kymera Therapeutics, Inc.. The most heavily invested institutionals were:
PRICE T ROWE ASSOCIATES INC /MD/: 6.87 M
BAKER BROS. ADVISORS LP: 6 M
WELLINGTON MANAGEMENT GROUP LLP: 5.31 M
BVF INC/IL: 5.16 M
Avoro Capital Advisors LLC: 5.15 M
Atlas Venture Life Science Advisors, LLC: 4.9 M
93.62% of Kymera Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 76.94 M shares in the last 24 months. This purchase volume represents approximately $3.07 B in transactions.